Aadi Bioscience

FDA Regulatory Profile

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0059-2023Class IIIFyarro (sirolimus protein-bound particles for injectable suspension (albumin-bound), 100 mg per vialOctober 13, 2022